Source: PharmaLive

PAI Analysis: Fishawack Health expands its value, evidence, and market access capabilities with acquisition of Policy Analysis Inc.

Fishawack Health (FH) - a leading commercialization partner for biopharmaceutical, medical technology, and wellness companies - welcomed the US-based health economics and outcomes research consultancy Policy Analysis Inc. (PAI) as part of the company's expanding Value, Evidence, and Access (VEA) capability.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Gerry Oster's photo - Managing Partner of PAI

Managing Partner

Gerry Oster

CEO Approval Rating

84/100

Read more